Theravance Biopharma TBPH

$ 14.05 0.86%

Quarterly report 2025-Q3
added 11-12-2025

Theravance Biopharma DPO Ratio 2011-2026 | TBPH

Annual DPO Ratio Theravance Biopharma

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	4.61 K	359	219	1.47 K	892	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
4.61 K	219	1.51 K

DPO Ratio of other stocks in the Biotechnology industry

	Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
	Acorda Therapeutics ACOR	277	-	-24.86 %	$ 820 K	USA
	Acasti Pharma ACST	4.39 K	-	4.01 %	$ 150 M	Canada
	Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
	I-Mab IMAB	2.24 K	-	-	$ 866 M	China
	AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
	Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
	Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
	Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
	Aptorum Group Limited APM	405	$ 0.82	4.22 %	$ 4.47 M	China
	Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
	BioCardia BCDA	68.1 K	$ 1.37	7.87 %	$ 29 M	USA
	Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
	Catalyst Biosciences CBIO	7.82	$ 11.29	-2.5 %	$ 1.01 B	USA
	Anika Therapeutics ANIK	54.4	$ 14.61	1.71 %	$ 214 M	USA
	AVEO Pharmaceuticals AVEO	235	-	-	$ 521 M	USA
	Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
	Aytu BioScience AYTU	186	$ 2.64	-	$ 16.6 M	USA
	CorMedix CRMD	79.3	$ 6.57	0.46 %	$ 473 K	USA